Cell-in-a-Box: PharmaCyte seeks FDA advice for inoper cancer trial
Cell In a box - Austrianova
Live Cell Encapsulation Technology - PharmaCyte Biotech
EX-99.1 2 pharmacyte_ex9901.htm PRESENTATION OF PHARMACYTE BIOTECH, INC. Exhibit
10-K 1 pharmacyte_10k-043021.htm FORM 10-K UNITED
May 21st 2020: Cells for Cells and Austrianova announce publication on novel method to produce stem cell exosomes - Austrianova
Cell-in-a-Box® Live Cell Encapsulation Nanotechnology
Cell-in-a-Box – Stock Market Media Group
PharmaCyte's Cell-in-a-Box encapsulation technology targeting cancer, diabetes - BioTuesdays
Cross-Disciplinary Efforts in Treating Diabetes
Work with Partners Using Cell-in-a-box - Austrianova
Live Cell Encapsulation Technology - PharmaCyte Biotech
Live Cell Encapsulation Technology - PharmaCyte Biotech
Pharmacyte Biotech : Company History, Executives, & Stock Value - DabConnection
PharmaCyte's Cell-in-a-Box encapsulation technology targeting cancer, diabetes - BioTuesdays
Eli Lilly Quietly Invests in Technology to Harness Human-Cell Messaging - BNN Bloomberg
PharmaCyte Biotech Study Proves Capsule Material Is Not Toxic For Encapsulated Cells
Home - Austrianova
Live Cell Encapsulation Technology - PharmaCyte Biotech
Live Cell Encapsulation Technology - PharmaCyte Biotech
PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation | Business Wire
Technology More
Real Tech Fund Invests in Austrianova, developing novel Encapsulation Technology of Cells & Bacteria
Cell-in-a-Box® Live Cell Encapsulation Nanotechnology
Cell In a box - Austrianova
Live Cell Encapsulation Technology - PharmaCyte Biotech
Sigma-Aldrich to launch Austrianova's encapsulation technology
Research & Development - PharmaCyte Biotech
Use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme Show
